09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
3564 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601<br />
Podnositelj europske MKP Broj objave europske Naziv izuma<br />
prijave patenta<br />
prijave patenta<br />
(71) (51) (97) (54)<br />
STMicroelectronics (Crolles 2) SAS, FR H01L 21/768 (2006.01)<br />
H01L 21/321 (2006.01)<br />
EP 2089900 *<br />
H01L 23/532 (2006.01)<br />
Styliaras, Vasilios, GR H01M 6/36 (2006.01)<br />
H01M 6/24 (2006.01)<br />
H01M 14/00 (2006.01)<br />
H01M 10/00 (2006.01)<br />
Sun Pharma Advanced Research<br />
Company Limited, IN<br />
C07D 271/06 (2006.01)<br />
C07D 413/10 (2006.01)<br />
C07D 413/14 (2006.01)<br />
A61K 31/4245 (2006.01)<br />
A61P 29/00 (2006.01)<br />
A61P 37/06 (2006.01)<br />
SuperGen, Inc., US C07D 487/04 (2006.01)<br />
A61K 31/5025 (2006.01)<br />
A61K 31/519 (2006.01)<br />
A61P 35/00 (2006.01)<br />
Syngenta Limited, GB A01N 43/653 (2006.01)<br />
A01N 25/02 (2006.01)<br />
A01N 25/22 (2006.01)<br />
A01P 3/00 (2006.01)<br />
B27K 3/50 (2006.01)<br />
Taisho Pharmaceutical Co. Ltd., JP C07D 211/58 (2006.01)<br />
A61K 31/4468 (2006.01)<br />
A61K 31/453 (2006.01)<br />
A61K 31/454 (2006.01)<br />
A61K 31/4545 (2006.01)<br />
A61K 31/496 (2006.01)<br />
A61K 31/506 (2006.01)<br />
A61K 31/5377 (2006.01)<br />
A61P 3/04 (2006.01)<br />
A61P 3/06 (2006.01)<br />
A61P 3/10 (2006.01)<br />
A61P 9/10 (2006.01)<br />
A61P 9/12 (2006.01)<br />
A61P 25/08 (2006.01)<br />
A61P 25/14 (2006.01)<br />
A61P 25/18 (2006.01)<br />
A61P 25/20 (2006.01)<br />
A61P 25/22 (2006.01)<br />
A61P 25/24 (2006.01)<br />
A61P 25/28 (2006.01)<br />
Taisho Pharmaceutical Co. Ltd., JP A61K 8/49 (2006.01)<br />
A61K 31/4245 (2006.01)<br />
A61P 17/14 (2006.01)<br />
A61Q 7/00 (2006.01)<br />
C07D 413/04 (2006.01)<br />
Takeda Pharmaceutical Company<br />
Limited, JP<br />
Takeda Pharmaceutical Company<br />
Limited, JP<br />
C07D 207/34 (2006.01)<br />
C07D 401/12 (2006.01)<br />
C07D 403/06 (2006.01)<br />
C07D 405/12 (2006.01)<br />
C07D 413/06 (2006.01)<br />
C07D 239/557 (2006.01)<br />
C07D 239/545 (2006.01)<br />
A61K 31/513 (2006.01)<br />
A61P 35/00 (2006.01)<br />
A61K 9/16 (2006.01)<br />
Takeda Pharmaceutical Company<br />
Limited, JP<br />
A61K 31/55 (2006.01)<br />
Targacept, Inc., US C07D 471/08 (2006.01)<br />
A61P 25/00 (2006.01)<br />
A61K 31/407 (2006.01)<br />
C07D 487/04 (2006.01)<br />
Tele Atlas B.V., NL G01S 5/14 (2006.01)<br />
Telefonaktiebolaget LM Ericsson (publ), H04L 29/12 (2006.01)<br />
SE<br />
Telefonaktiebolaget LM Ericsson (publ), H04L 29/06 (2006.01)<br />
SE<br />
H04Q 7/32 (9999.12)<br />
Telefonaktiebolaget LM Ericsson (publ),<br />
SE<br />
H04Q 7/38 (9999.12)<br />
H04B 1/707 (2006.01)<br />
H04B 7/08 (2006.01)<br />
H04B 17/00 (2006.01)<br />
Telefonaktiebolaget LM Ericsson (publ), H04L 29/12 (2006.01)<br />
SE<br />
Telethon Institute for Child Health C12Q 1/68 (2006.01)<br />
Research, AU<br />
G01N 33/53 (2006.01)<br />
EP 2089926 *<br />
EP 2014653<br />
EP 2086979 *<br />
EP 2<strong>09</strong>6920 *<br />
EP 2<strong>09</strong>85<strong>09</strong> *<br />
EP 2100588 *<br />
EP 2089359 *<br />
EP 2<strong>09</strong>1941 *<br />
EP 2<strong>09</strong>4246 *<br />
EP 2<strong>09</strong>4703 *<br />
EP 2<strong>09</strong>5148 *<br />
EP 2087711 *<br />
EP 2<strong>09</strong>2714 *<br />
EP 2<strong>09</strong>5523 *<br />
EP 2<strong>09</strong>8045 *<br />
EP 2<strong>09</strong>3297<br />
FABRICATION OF A DIFFUSION BARRIER CAP ON<br />
COPPER CONTAINING CONDUCTIVE ELEMENTS<br />
ELECTRIC ENERGY PRODUCTION BY VOLTAIC<br />
CELL SOLUTION TEMPERATURE CHANGE<br />
Novel dicarboxylic acid derivatives as S1P1 receptor<br />
agonists<br />
IMIDAZOÝ1,2-B¨PYRIDAZINE AND PYRAZOLOÝ1,5-<br />
A¨PYRIMIDINE DERIVATIVES AND THEIR USE AS<br />
PROTEIN KINASE INHIBITORS<br />
TRIAZOLE FORMULATION<br />
1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE<br />
PROPHYLACTIC OR THERAPEUTIC AGENT FOR<br />
ALOPECIA<br />
MAPK/ERK KINASE INHIBITORS<br />
MAPK/ERK KINASE INHIBITORS<br />
SUSTAINED-RELEASE COMPOSITION AND METHOD<br />
FOR PRODUCING THE SAME<br />
NICOTINIC ACETYLCHOLINE RECEPTORSUB-TYPE<br />
SELECTIVE AMIDES OF DIAZABICYCLOALKANES<br />
ARRANGEMENT FOR AND METHOD OF TWO<br />
DIMENSIONAL AND THREE DIMENSIONAL<br />
PRECISION LOCATION AND ORIENTATION<br />
DETERMINATION<br />
METHOD AND APPARATUS FOR IP NETWORK<br />
INTERFACING<br />
METHOD FOR FAST HANDOVER AND<br />
AUTHENTICATION IN A PACKET DATA NETWORK<br />
EFFICIENT DELAY PROFILE COMPUTATION WITH<br />
RECEIVE DIVERSITY<br />
NODE REGISTERING METHOD<br />
Agents for treatment or prevention of an allergic disorder<br />
ISSN 1331-2030